Recombinant IL1RL1 (Astegolimab Biosimilar) antibody

Catalog No. ABIN7597519

The Human Monoclonal anti-IL1RL1 (Astegolimab Biosimilar) antibody has been validated for . It is suitable to detect IL1RL1 (Astegolimab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL1RL1 (Astegolimab Biosimilar) antibody (ABIN7597519)

Target: IL1RL1 (Astegolimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL1RL1 (Astegolimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL1RL1 (Astegolimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Astegolimab Biosimilar Antibody

Specificity: T1, DER4, Interleukin-1 receptor-like 1, ST2, IL1RL1, Protein ST2

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.91 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL1RL1 (Astegolimab Biosimilar)

Target: IL1RL1 (Astegolimab Biosimilar)

Alternative Name: Astegolimab Biosimilar

Target Type: Biosimilar

Background: T1, DER4, Interleukin-1 receptor-like 1, ST2, IL1RL1, Protein ST2

UniProt: Q01638

CAS-No: 2173054-79-8